News - See what's new!
Find all the latest information on upcoming events, product developments, and company announcements.
Dr. Sergott Discusses Benefits of MultiColor Fundus Imaging at AAO
Neuro-ophthalmologist Dr. Robert (Bob) Sergott discusses with Healio| OSN the clinical value of MultiColor fundus imaging with SPECTRALIS® at the annual American Academy of Ophthalmology meeting in New Orleans, LA.
Read moreWhat Multimodal Imaging Can Reveal with the Unclear Diagnosis Webinar
Dr. Vakharia (Retina Vitreous Associates of Florida) educates on how a combination of Multimodal diagnostic imaging can demystify challenging cases and increase clinical confidence.
Read moreRoyal Victoria Infirmary utilises diagnostic hubs to provide greater access to sight-saving care
The Royal Victoria Infirmary (RVI) in Newcastle upon Tyne, UK, is utilising a diagnostic hub model to offer more people with sight threatening conditions timely treatment, when pressures on services due to the pandemic have caused inevitable delays.
Read moreNew Webinar: Multimodal Imaging in a Virtual Clinic – Diagnosis of Posterior Pathology
The webinar Multimodal Imaging in the Diagnosis of Posterior Pathology will explore how the effective use of multimodal imaging (OCT, enhanced depth imaging, autofluorescence, infrared, and MultiColor) in virtual clinics with a multidisciplinary team, allows accurate diagnosis of posterior pathology without the need for face-to-face consultation.
Read moreDiagnostic imaging in patient with liquefied aftercataract
A new case presentation in the American Journal of Ophthalmology Case Reports provides additional evidence on how ANTERION® images can make a difference in clinical diagnosis and follow-up.
Read moreHigh-quality, repeatable imaging is the cornerstone of managing diabetic eye disease
In the article “Managing diabetic eye disease eased with repeatable, high-quality imaging” recently published in Modern Retina, Dr. David Eichenbaum highlights various SPECTRALIS multimodal imaging platform features and their benefits in managing diabetic eye disease. He delves into the importance of having dependable and consistent imaging capability within the retina practice.
Read moreReflections on durable therapies for diabetic macular edema amid COVID-19 pandemic
An article in Ophthalmology Times by Dr. Caesar Luo overviews considerations for sustainable DME management options during the everchanging COVID-19 healthcare landscape, with an emphasis on the backlog caused by patients’ reluctance to visit clinics during the pandemic. It includes an interesting case study imaged using a SPECTRALIS OCT.
Read moreNOTICE: LOG4SHELL GAP
The Log4Shell gap is a global security risk that affects a commonly used Java logging library (Log4j). We are pleased to inform you that no Heidelberg Engineering product is affected by the Log4j vulnerability, this includes products designed and manufactured by our subsidiaries, MedicalCommunications and Medisoft.
Read moreAcceptance for SPECTRALIS SHIFT Technology under new EU Medical Device Regulation
With the introduction of an innovative new technology, SPECTRALIS® users will be able to choose the most suitable OCT scan speed for each individual patient. Standard presets ensure an efficient workflow, while practitioners are flexible to modify the OCT acquisition speed to strike the ideal balance between speed and image quality.
Read moreSPECTRALIS News | November 2021
This edition of SPECTRALIS News highlights examples of diagnostic support provided by the SPECTRALIS® MultiColor Module. Enjoy reading about studies by renowned experts and a useful tutorial.
Read more